Phoenix, AZ7 Active Studies

Major Depressive Disorder Clinical Trials in Phoenix, AZ

Find 7 actively recruiting major depressive disorder clinical trials in Phoenix, AZ. Connect with local research sites and explore new treatment options.

7
Active Trials
6
Sponsors
1,706
Enrolling

Recruiting Major Depressive Disorder Studies in Phoenix

About Major Depressive Disorder Clinical Trials in Phoenix

Major depressive disorder (MDD) is a severe form of depression characterized by persistent sadness, loss of interest, and impaired daily functioning. Treatment-resistant depression (TRD) affects patients who do not respond to standard therapies. Novel treatments like ketamine, psilocybin, and neuromodulation are being studied.

There are currently 7 major depressive disorder clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 1,706 participants. Research is being sponsored by Vanda Pharmaceuticals, Alto Neuroscience, Autobahn Therapeutics, Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Major Depressive Disorder Clinical Trials in Phoenix — FAQ

Are there major depressive disorder clinical trials in Phoenix?

Yes, there are 7 major depressive disorder clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What major depressive disorder treatments are being tested?

The 7 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for major depressive disorder.

Data updated October 18, 2026 from ClinicalTrials.gov